Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran vs Gabapentin vs Combination in Fibromyalgia
NCT05384210Unknown
- Sponsor
- Mansoura University
- Start
- Jun 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of milnacipran and gabapentin in fibromyalgia syndrome (FMS), sponsored by Mansoura University. Primary endpoint: Visual Analogue Scale at 3 months. Status: unknown.
02
Drugs
milnaciprangabapentin
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT05384210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384210.